Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience at UCL and Co-Founder and CSO of Nanomerics, gave one of this year's keynote presentations at ...
If every American over the age of 40 was as physically active as the top 25% of the population, they ...
Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating ...
Study supports the hypothesis that a healthy cardiovascular system may increase the likelihood of migraines, particularly in women. Study: Cardiovascular ...
Researchers from 15 countries, led by Amsterdam UMC, have developed a way to predict which patients are at risk of ...
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, ...
A new paper in Rheumatology, published by Oxford University Press, finds that consuming more caffeine may improve heart health. Vascular ...
New research from a large Nordic cohort study suggests that prolonged exposure to road and aircraft noise may elevate the ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net